Key result
Isoproterenol reduces myocardial creatine kinase activity by ~59% compared to controls.
Why the study?
Quantitative methods to assess infarct size in isoproterenol-induced myocardial lesions in rats require validation and comparison.
Absolute Event Rate: 6.1% vs 14.91%
p-value: p=<0.001
Hypothesis-generating in animal model; does not inform clinical practice and requires human validation.
The authors performed a number of experiments aiming at quantifying the infarct size in Sprague-Dawley male rats. The experimental model employed was isoproterenol (ISP) induced, infarctlike myocardial lesions. In quantifying the extent of the infarct area they compared the cross reliability of enzymatic and histological methods. ISP was administered in two subcutaneous injections (50 mg/100 Gm body weight) at a 24 hour interval. At the peak of the necrotic process (48 hrs after the first injection), the heart was subjected to enzymatic or histological studies. Thus, a group of infarcted animals (n = 25) and their controls (n = 15) underwent the assessment of creatine kinase (CK) content in the homogenate of the myocardium. Another group of animals (n = 15) was used for histological observations, including measurement of infarct size by planimetry from histological sections. A good relationship was observed between the percentage of necrotic tissue calculated on the basis of CK values (69.11 +/- 2.39%) and the infarction area assessed by planimetry (72.37 +/- 2.69%) (mean +/- standard error of the mean [SEM]). Thus, the present study confirms that ISP-induced myocardial lesions are a simple and reliable model for experimental infarct. Moreover, the assessment of the CK content in the heart is correlated with histological studies by planimetry, and is suggested as a direct enzymatic method to quantify the extent of myocardial necrosis.
No takes yet. Share an insight, caveat, or question.
Genovese et al. (1982) studied Isoproterenol-induced myocardial infarction (n=80). Isoproterenol vs. Control was evaluated on Myocardial creatine kinase (CK) values (IU/mg protein) (p=<0.001). Isoproterenol administration significantly reduced myocardial creatine kinase activity to 6.10 IU/mg protein compared to 14.91 IU/mg protein in controls (p<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: